about
Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs.Urinary PGE-M in colorectal cancer: predicting more than risk?Urinary prostaglandin E2 metabolite and breast cancer risk.Interactions between meat intake and genetic variation in relation to colorectal cancer.Fruit and vegetable intake and urinary levels of prostaglandin E₂ metabolite in postmenopausal women.Factors Associated with Multiple Biomarkers of Systemic Inflammation.2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco Smoke.ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers.PUFA levels in erythrocyte membrane phospholipids are differentially associated with colorectal adenoma risk.Aspirin and colorectal cancer: the promise of precision chemoprevention.Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.Circulating prostaglandins as biomarkers for colorectal cancer?Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial.Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer.
P2860
Q33857191-A11B6EE2-35C2-41F8-9DFE-F1D9DBF311A9Q34289285-A84C406C-D133-4C2F-A89F-83C1E6007B14Q34641787-D1CD1DDC-5290-402B-811A-44CDE0463DB6Q34664123-779FCB6F-16DE-4C54-9CF0-DCB9DC8693CFQ36654662-D0BD9E67-03C7-4C90-A0AD-C99E1E154DF7Q36655802-9C276662-D0ED-4D5A-8DD0-49E0E9E0044AQ37059818-33DD7C51-78A9-42D3-80B6-3A7E090CDAD5Q37618698-3DAAA14A-C3F5-4754-A15E-3A9372FC9E34Q37643215-30C15E92-C34D-4AA2-8F85-E5ACDB17B60AQ38702973-D71446F5-A904-4080-9855-D426A33633A0Q38730064-8E16FB71-9D1D-4FA6-899A-476FD0653DB7Q38927355-23E616FE-E806-4A37-97FC-E3D7FDFA1A7EQ40080359-06AFEC8E-5213-47AF-9043-F248F0A2A5BEQ41142487-3751FE0E-D733-4E81-A51E-F69589ECD65AQ41561509-521CEA5A-0522-43D1-A20F-7C290B0BD321Q41624931-8C6C2912-6C00-444F-96B8-2D38B47852A3Q47341907-EBB3A146-074A-40AC-A74C-C4FD8AE76C88Q53528564-6079E787-B3BA-40BE-A461-2A9FA2900687
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary PGE-M: a promising cancer biomarker
@en
Urinary PGE-M: a promising cancer biomarker.
@nl
type
label
Urinary PGE-M: a promising cancer biomarker
@en
Urinary PGE-M: a promising cancer biomarker.
@nl
prefLabel
Urinary PGE-M: a promising cancer biomarker
@en
Urinary PGE-M: a promising cancer biomarker.
@nl
P2860
P1476
Urinary PGE-M: a promising cancer biomarker
@en
P2093
Dingzhi Wang
Raymond N DuBois
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0153
P577
2013-05-01T00:00:00Z